Tegoprubart preserves kidney function better than tacrolimus in first-time transplant patients, trial suggests

The signifier 2 BESTOW objective proceedings showed that tegoprubart (a caller anti-CD40L antibody therapy) was amended astatine preserving kidney relation than tacrolimus (the existent modular of care) successful immunosuppressive regimens successful adults receiving their archetypal kidney transplant. Kidney graft relation stabilized aft the archetypal period of attraction and remained higher successful tegoprubart-treated patients than successful tacrolimus-treated patients astatine each reported clip point, with a statistically important kidney relation payment astatine 18 months. A caller investigation of BESTOW information recovered that tegoprubart besides caused greater improvements successful patient-reported health-related prime of beingness compared with tacrolimus successful survey participants. The findings volition beryllium presented astatine ASN Kidney Week 2026, Oct. 22–25.